GAMMA Investing’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.67K Buy
+3,406
New +$6.69K ﹤0.01% 3681
2026
Q1
– Sell
-30
Closed -$155 – 4203
2025
Q4
$155 Sell
30
-30
-50% -$145 ﹤0.01% 4026
2025
Q3
$253 Buy
+60
New +$279 ﹤0.01% 3789
2025
Q2
– Sell
-238
Closed -$1.03K – 3864
2025
Q1
$1.03K Buy
+238
New +$961 ﹤0.01% 3554

Other funds holding ORGO

GAMMA Investing's ORGO Position: Q3 2026 in Review

GAMMA Investing opened a new position in Organogenesis Holdings (ORGO) in Q3 2026: 3,406 shares worth $4.67K. The stake represents ﹤0.01% of the portfolio and ranks #3681 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in ORGO as recently as Q4 2025.

GAMMA Investing first reported a position in ORGO in Q1 2025 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • GAMMA Investing held 3,406 shares of Organogenesis Holdings worth $4.67K as of Q3 2026.
  • Organogenesis Holdings was a new GAMMA Investing position in Q3 2026.
  • Organogenesis Holdings made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3681 holding.
  • GAMMA Investing first reported a position in Organogenesis Holdings in Q1 2025 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.